This getting demonstrates plasticity, the ability of a brain region to change its functioning, in the adult mind. The finding will not lead immediately to treatments, but may eventually play a role in designing new therapies to aid recovery following mind and stroke injury, say the authors, in the September 5 issue of The Journal of Neuroscience whose study appears. Daniel Dilks, PhD, of Massachusetts Institute of Technology, and co-workers studied a 51-year-old man six months after he suffered a stroke. It damaged nerve fibers that transmitted info from his eye to one region of his visual cortex, which processes visible inputs, rendering him partially blind.The KFDA required extensive data on clinical results, safety, device design and biocompatibility. ‘We are really thrilled to be able to offer this advanced vision correction technology in Korea,’ stated Ed Peterson, AcuFocus President and Chief Executive Officer. ‘The approval from the KFDA is normally a testament to the wonderful global results achieved with the device.’ Related StoriesLaser eye surgery: a glimpse into the future – An interview with Professor Dan ReinsteinCurrent challenges in tackling macular degeneration: an interview with Mark Ackermann, AMD Alliance InternationalCurrent and fresh treatments for AMD: an interview with Dr Alan Cruess, AMD Alliance International Over one third of the Korean populace is currently struggling with vision loss associated with presbyopia, and that’s projected to boost to over 42 percent by the year 2020 [MarketScope].